Multiple cellular enzymes and pathways (None)

The term Multiple cellular enzymes and pathways refers to a broad, non-specific category used to describe the pharmacological profile of drugs that do not interact with a single, discrete molecular target. This designation is frequently applied to agents like general anesthetics (e.g., Sevoflurane) and alcohols (e.g., Ethanol), which exert their effects by modulating the activity of numerous proteins, ion channels, and cellular membranes simultaneously (DrugBank Online, 2024). Because these substances lack high-affinity binding to a specific receptor, their clinical efficacy and side-effect profiles are the result of cumulative actions across diverse biological systems (PubMed, PMID: 28836595). In a therapeutic context, this classification indicates a pleiotropic mechanism of action where identifying a primary target is either scientifically inappropriate or currently impossible due to the complexity of the drug's interactions. Consequently, this entry is considered a descriptive grouping rather than a canonical therapeutic target. This lack of specificity often presents challenges in drug development, particularly regarding the prediction of off-target effects and systemic toxicity (National Center for Biotechnology Information, 2024).

Other names

Multi-targetNon-specific cellular targetsPleiotropic targetsNon-specific molecular targetsVarious enzymes and pathways

Non-specific modulation of various cellular components including enzymes, ion channels, and lipid membranes (DrugBank Online, 2024).